← SynDRA
CEP-33779
SynDRA canonical compound SYN0086589 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | JAK2 |
|---|
| Mechanism of action | JAK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- JAK inhibitor
- JAK2 INHIBITOR
- JAK3 INHIBITOR
Cross-references
Synonyms
- CEP33779
- TE2YU6E6YP
- RefChem:918221
- MFCD22683932
- C24H26N6O2S
- RFZKSQIFOZZIAQ-UHFFFAOYSA-N
- MLS006011248
- GTPL9387
- orb1301054
- SCHEMBL2634485
- SCHEMBL30925315
- BDBM99537
- GLXC-03812
- HMS3651D13
- EX-A1032
- WDC16857
- CEP33779?
- s2806
- AKOS025404934
- CCG-265001
- CS-3439
- SB19296
- SDCCGSBI-0654480.P001
- compound 29 [PMID: 22594690]
- NCGC00345854-01
- NCGC00345854-06
- NCGC00345854-10
- AC-32809
- AC-38015
- AS-16293
- FC137660
- HY-15343
- SMR004703007
- SW219454-1
- T6122
- US8501936, 35
- F860356
- BRD-K37237504-001-02-7
Look up CEP-33779 in the interactive SynDRA portal →